Select Publications
Journal articles
2024, 'James Crawford Biggs 1931-2023', Bone marrow transplantation, 59, pp. 291 - 292, http://dx.doi.org/10.1038/s41409-023-02170-6
,2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926
,2022, 'Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience', Internal Medicine Journal, 52, pp. 57 - 62, http://dx.doi.org/10.1111/imj.15128
,2021, 'Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-147106
,2019, 'Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005–2015', Bone Marrow Transplantation, 54, pp. 1973 - 1986, http://dx.doi.org/10.1038/s41409-019-0554-9
,2018, 'Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis', Bone Marrow Transplantation, 53, pp. 1478 - 1482, http://dx.doi.org/10.1038/s41409-018-0215-4
,2018, 'CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry', International Journal of Laboratory Hematology, 40, pp. 533 - 539, http://dx.doi.org/10.1111/ijlh.12857
,2018, '‘Real-world’ Australian experience of pomalidomide for relapsed and refractory myeloma', Leukemia and Lymphoma, 59, pp. 1514 - 1516, http://dx.doi.org/10.1080/10428194.2017.1387911
,2018, 'Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand', Biology of Blood and Marrow Transplantation, 24, pp. 169 - 174, http://dx.doi.org/10.1016/j.bbmt.2017.09.011
,2018, 'Activity and Capacity Profile of Transplant Physicians and Centres in Australia and New Zealand', Biology of Blood and Marrow Transplantation, 24, pp. S310 - S311, http://dx.doi.org/10.1016/j.bbmt.2017.12.319
,2017, 'Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma', BRITISH JOURNAL OF HAEMATOLOGY, 178, pp. 250 - 256, http://dx.doi.org/10.1111/bjh.14667
,2017, 'Mid-life extra-haematopoetic manifestations of Diamond-Blackfan anaemia', ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, http://dx.doi.org/10.1530/EDM-16-0141
,2017, 'Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases', Pediatric Blood and Cancer, 64, pp. 197 - 202, http://dx.doi.org/10.1002/pbc.26219
,2016, 'All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: A retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand', Bone Marrow Transplantation, 51, pp. 1400 - 1403, http://dx.doi.org/10.1038/bmt.2016.143
,2016, 'Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study', Biology of Blood and Marrow Transplantation, 22, pp. 949 - 956, http://dx.doi.org/10.1016/j.bbmt.2016.01.027
,2016, 'A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013', Biology of Blood and Marrow Transplantation, 22, pp. 284 - 291, http://dx.doi.org/10.1016/j.bbmt.2015.09.009
,2015, 'Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin Lymphoma', Blood, 126, pp. 3961 - 3961, http://dx.doi.org/10.1182/blood.v126.23.3961.3961
,2015, 'Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy', Leukemia, 29, pp. 441 - 447, http://dx.doi.org/10.1038/leu.2014.203
,2015, 'Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors', Journal of Heart and Lung Transplantation, 34, pp. 1406 - 1414, http://dx.doi.org/10.1016/j.healun.2015.05.021
,2014, 'Iron deficiency anaemia: Causes, symptoms and treatment', Medicine Today, 15, pp. 36 - 42
,2014, 'Invasive pneumococcal disease following adult allogeneic hematopoietic stem cell transplantation', Transplant Infectious Disease, 16, pp. 751 - 759, http://dx.doi.org/10.1111/tid.12268
,2014, 'Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: A population-based cohort study', Bone Marrow Transplantation, 49, pp. 691 - 698, http://dx.doi.org/10.1038/bmt.2014.13
,2014, 'A Population-Based Cohort Study of Late Mortality in Adult Autologous Hematopoietic Stem Cell Transplant Recipients in Australia', Biology of Blood and Marrow Transplantation, 20, pp. 937 - 945, http://dx.doi.org/10.1016/j.bbmt.2014.03.006
,2013, 'Protease Inhibitor Vs. Non-Protease Inhibitor Based Antiretroviral Therapy In HIV-Infected Patients With Hodgkin and Non-Hodgkin Lymphoma Receiving Chemotherapy', Blood, 122, pp. 3843 - 3843, http://dx.doi.org/10.1182/blood.v122.21.3843.3843
,2013, 'A population-based analysis of the effect of autologous hematopoietic cell transplant in the treatment of multiple myeloma', Leukemia and Lymphoma, 54, pp. 1671 - 1676, http://dx.doi.org/10.3109/10428194.2013.763396
,2013, 'Plasma cell myeloma ‘masquerading’ morphologically as a storage disorder', Pathology, 45, pp. S96 - S96, http://dx.doi.org/10.1097/01.pat.0000426989.58960.aa
,2012, 'Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk', Biology of Blood and Marrow Transplantation, 18, pp. 302 - 308, http://dx.doi.org/10.1016/j.bbmt.2011.05.003
,2011, 'Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998–2006: factors associated with improved survival outcome', Leukemia & Lymphoma, pp. 1 - 9, http://dx.doi.org/10.3109/01443615.2011.582201
,2011, 'Allogeneic hematopoietic cell transplantation for multiple myeloma using reduced intensity conditioning therapy, 18-2006, factors assoicated with improved survival outcome', Leukemia and Lymphoma, 52, pp. 1727 - 1735
,2011, 'Increased activity and improved outcome in unrelatred donor haemopoietic stem cell transplants for acute myeloid leukaemia in Australia, 1992-2005', Internal Medicine Journal, 41, pp. 27 - 34
,2010, 'Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation', Bone Marrow Transplantation, 45, pp. 1068 - 1076
,2010, 'Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia', British Journal of Haematology, 148, pp. 623 - 626
,2009, 'Late mortality and relapse following BuCy2 and HLA-Identical sibling marrow transplantation for chronic myelogenous leukemia', Biology of Blood and Marrow Transplantation, 15, pp. 851 - 855
,2009, 'Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates', Biology of Blood and Marrow Transplantation, 15, pp. 1323 - 1330
,2008, 'Incidence of Late Failure Following Myeloablative Conditioning with BuCy2 and Matched Sibling Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia.', Blood, 112, pp. 2172 - 2172, http://dx.doi.org/10.1182/blood.v112.11.2172.2172
,2008, 'Late Mortality and Relapse Following HLA-Identical Sibling Donor Marrow Transplantation for Chronic Myeloid Leukemia.', Blood, 112, pp. 3264 - 3264, http://dx.doi.org/10.1182/blood.v112.11.3264.3264
,2008, 'Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD 133(+) cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascul', American Heart Journal, 156, pp. 954 - 963
,2007, 'Abstract 2669: The Use of Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization: the GAIN I study', Circulation, 116, http://dx.doi.org/10.1161/circ.116.suppl_16.ii_591-d
,2007, 'Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia', Biology of Blood and Marrow Transplantation, 13, pp. 601 - 607
,2007, 'Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004', Biology of Blood and Marrow Transplantation, 13, pp. 905 - 912
,2007, 'Lung transplantation after allogeneic haematopoietic stem cell transplantation', Haematologica - the Hematology Journal, 92, pp. 216 - 216
,2006, 'Long-Term Follow-Up of Treatment for Acute Myeloid Leukemia with Allogeneic Hematopoetic Cell Transplantation Using BuCy2 as Preparation.', Blood, 108, pp. 3370 - 3370, http://dx.doi.org/10.1182/blood.v108.11.3370.3370
,2006, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic stem cell transplantation (SCT) for AML', Biology of Blood and Marrow Transplantation, 12, pp. 27 - 27
,2006, 'A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogenic haemopoietic stem cell transplant recipients', European Journal of Haematology, 77, pp. 425 - 431
,2006, 'Haemopoietic stem cell transplants for chronic myelofibrosis - A review from the ABMTRR', Biology of Blood and Marrow Transplantation, 12, pp. 32 - 33
,2006, 'Long term follow-up of patients with chronic myeloid leukemia receiving BuCy2 as preparation for allotransplantation', Blood, 108, pp. 960A - 960A
,2006, 'Measurement of mortality in long-term hemopoietic stem cell transplant survivors', Biology of Blood and Marrow Transplantation, 12, pp. 108 - 108
,2005, 'A SYBR Green - Based Real Time PCR Method for Detection of Haemopoietic Chimerism in Allogeneic Stem Cell Transplant Recipients.', Blood, 106, pp. 5222 - 5222, http://dx.doi.org/10.1182/blood.v106.11.5222.5222
,2005, 'Cytomegalovirus Viraemia after Allogeneic Transplant: A Prospective Study of a Risk-Adapted Strategy in a Single Transplant Unit.', Blood, 106, pp. 5374 - 5374, http://dx.doi.org/10.1182/blood.v106.11.5374.5374
,2005, 'Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.', Blood, 106, pp. 4215 - 4215, http://dx.doi.org/10.1182/blood.v106.11.4215.4215
,